Lilly seeks to protect interests in compounded drug case FDA affirms no shortage of tirzepatide drugs Compounded versions cheaper, often not covered by insurers Jan 2 (Reuters) - Eli Lilly (LLY.N ...

In the time since, though, some analysts have said the reaction is overblown, particularly for weight-loss drugmakers like Wegovy, and Ozempic maker Novo Nordisk and Zepbound maker Eli Lilly.

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other stocks. In his second appearance on Squawk on the Street after the Fed's interest ...

The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved and that specialty pharmacies and online companies need to stop ...

All you need to do is wear them and focus on the swim. Why you can trust Live Science Our expert reviewers spend hours testing and comparing products and services so you can choose the best ones ...

whose investigation into Cambridge Analytica earned her a nomination for the Pulitzer Prize in 2019. The journalist is also well known for her long-running legal row with Brexit campaigner Arron ...

The rights to a catalog of prints from Lilly Pulitzer's early years — including many created by the artist the famed fashion designer credited with the "Lilly Look" — are now officially part ...

The rights to a catalog of prints from Lilly Pulitzer's early years — including many created by the artist the famed fashion designer credited with the "Lilly Look" — are now officially part of the ...

Sleep apnea, a sleep disorder typically managed with a medical device that aids in breathing, now has its first FDA-approved drug therapy, an Eli Lilly medicine initially developed as a treatment ...